SCHEMBL28808683

SCHEMBL28808683

CC(C)(O)c1cccc(-n2ccnc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.55
CYP3A4 P08684 3/20 0.51
CYP11B1 P15538 2/20 0.47
CYP11B2 P19099 2/20 0.47
CYP19A1 P11511 2/20 0.47
CYP2A6 P11509 1/20 0.47
ENPP2 Q13822 1/20 0.45
MKNK1 Q9BUB5 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
NCOA3 Q9Y6Q9 1/20 0.43
BAZ2B Q9UIF8 1/20 0.43
MEN1 O00255 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
MAP3K5 Q99683 1/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4404018 0.87 IDO1 (0.58) IDO1CYP3A4CYP11B1CYP11B2CYP19A1
SCHEMBL6649233 0.81 IDO1 (0.58) IDO1CYP3A4CYP11B1CYP11B2CYP19A1
SCHEMBL14489499 0.79 IDO1 (0.75) IDO1CYP3A4CYP11B1CYP11B2CYP19A1
SCHEMBL13320411 0.78 IDO1 (0.55) IDO1CYP3A4CYP11B1CYP11B2CYP19A1
SCHEMBL28781325 0.76 IDO1 (0.46) IDO1CYP3A4CYP11B1CYP11B2CYP19A1
SCHEMBL17758894 0.76 IDO1 (0.47) IDO1CYP3A4CYP11B1CYP11B2CYP19A1
SCHEMBL872242 0.75 IDO1 (0.64) IDO1CYP3A4CYP11B1CYP11B2CYP19A1
SCHEMBL29483362 0.75 IDO1 (0.64) IDO1CYP3A4CYP11B1CYP11B2CYP19A1
SCHEMBL3071130 0.75 IDO1 (0.64) IDO1CYP3A4CYP11B1CYP11B2CYP19A1
SCHEMBL1895055 0.74 RXRA (0.35) CYP3A4CYP11B1CYP11B2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102014900-B Method of treating cancer using a neuropeptide Y5R (NPY5R) antagonist UNIV HEALTH NETWORK 2014-04-02 CN disclosed